LAMPROPOULOS FRED P 4

4 · MERIT MEDICAL SYSTEMS INC · Filed Mar 6, 2025

Insider Transaction Report

Form 4

Period: 2025-03-05

MERIT MEDICAL SYSTEMS INCMMSI

LAMPROPOULOS FRED P

DirectorPresident & CEO

Transactions

Sale
Common Stock, No Par Value
2025-03-05$103.75/sh−2,590.001$268,713→ 7,734.258 total(indirect: By Spouse)
Sale
Common Stock, No Par Value
2025-03-05$104.05/sh−11,320$1,177,846→ 1,106,028 total
Sale
Common Stock, No Par Value
2025-03-05$103.75/sh−20,000$2,075,000→ 1,086,028 total
Sale
Common Stock, No Par Value
2025-03-05$103.75/sh−409.741$42,511→ 10,324.259 total(indirect: By Spouse)

Holdings

Common Stock, No Par Value
(indirect: By Spouse)
90
Non-qualified stock options (right to buy)
Exercise: $55.73From: 2020-03-01Exp: 2026-03-01→ Common Stock (159,151 underlying)
159,151
Non-qualified stock options (right to buy)
(indirect: By Spouse)
Exercise: $55.73From: 2020-03-01Exp: 2026-03-01→ Common Stock (2,000 underlying)
2,000
Non-qualified stock options (right to buy)
Exercise: $37.71From: 2021-02-26Exp: 2027-02-26→ Common Stock (100,334 underlying)
100,334
Non-qualified stock options (right to buy)
Exercise: $56.25From: 2022-03-19Exp: 2028-03-19→ Common Stock (58,083 underlying)
58,083
Common Stock, No Par Value
(indirect: By 401(k))
97,798
Non-qualified stock options (right to buy)
Exercise: $70.58From: 2024-02-28Exp: 2030-02-28→ Common Stock (54,302 underlying)
54,302

Footnotes (9)

[F1]Represents plan holdings as of 02/28/2025.
[F2]Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse.
[F3]The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.00 to $104.22, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F4]The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.75 to $103.765, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F5]Becomes exercisable in equal annual installments of 20% commencing 3/1/2020.
[F6]Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/1/2020. Options not vested as of 6/22/2020 have been forfeited.
[F7]Becomes exercisable in equal annual installments of 25% commencing 2/26/2021.
[F8]Becomes exercisable in equal annual installments of 25% commencing 03/19/2022.
[F9]Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.

Documents

1 file

4
form4-03062025_100305.xmlPrimary